Canada - English - Health Canada

teva canada limited - hydrocortisone (hydrocortisone sodium succinate) - powder for solution - 250mg - hydrocortisone (hydrocortisone sodium succinate) 250mg - adrenals

Canada - English - Health Canada

teva canada limited - hydrocortisone (hydrocortisone sodium succinate) - powder for solution - 100mg - hydrocortisone (hydrocortisone sodium succinate) 100mg - adrenals

Malta - English - Medicines Authority

panpharma z.i. du clairay, 35133 luitre, france - hydrocortisone sodium, succinate - powder for solution for infusion or injection - hydrocortisone sodium succinate 133.7 mg - corticosteroids for systemic use

Canada - English - Health Canada

hikma canada limited - hydrocortisone (hydrocortisone sodium succinate) - powder for solution - 100mg - hydrocortisone (hydrocortisone sodium succinate) 100mg - adrenals

Canada - English - Health Canada

hikma canada limited - hydrocortisone (hydrocortisone sodium succinate) - powder for solution - 250mg - hydrocortisone (hydrocortisone sodium succinate) 250mg - adrenals

Kenya - English - Pharmacy and Poisons Board

medisel kenya ltd p.o box 540-01000 thika - hydrocortisone sodium succinate - injection - hydrocortisone sodium succinate injection bp 100… - plain corticosteroids for systemic use:

Australia - English - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - hydrocortisone sodium succinate, quantity: 133.7 mg - injection, powder for - excipient ingredients: - when oral therapy is not feasible, and the strength, form and route of administration of,the drug reasonably lend the preparation to the treatment of the condition,,hydrocortisone-aft powder for injection is indicated for intravenous or intramuscular,use in the following conditions:,1. endocrine disorders,? primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is,the drug of choice; synthetic analogues may be used in conjunction with,mineralocorticoids where applicable; in infancy, mineralocorticoid,supplementation is of particular importance). acute adrenocortical insufficiency,(hydrocortisone or cortisone is the drug of choice; mineralocorticoid supplements,may be necessary, particularly when synthetic analogues are used).,? preoperatively and in the event of serious trauma or illness, in patients with,known adrenal insufficiency or when adrenocortical reserve is doubtful,? shock unresponsive to conventional therapy if adrenocortical insufficiency exists,or is suspected,? congenital adrenal hyperplasia,? nonsuppurative thyroiditis,? hypercalcaemia associated with cancer,2. rheumatic disorders,as adjunctive therapy for short-term administration (to tide the patient over an acute,episode or exacerbation) in:,? post-traumatic osteoarthritis,? synovitis of osteoarthritis,? rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may,require low dose maintenance therapy),? acute and subacute bursitis,? epicondylitis,? acute nonspecific tenosynovitis,? acute gouty arthritis,? psoriatic arthritis,? ankylosing spondylitis,3. collagen diseases,during an exacerbation or as maintenance therapy in selected cases of:,? systemic lupus erythematosus,? systemic dermatomyositis (polymyositis),? acute rheumatic carditis,4. dermatological diseases,? pemphigus,? severe erythema multiforme (stevens-johnson syndrome),? exfoliative dermatitis,? bullous dermatitis herpetiformis,? severe seborrhoeic dermatitis,? severe psoriasis,? mycosis fungoides,5. allergic states,control of severe or incapacitating allergic conditions intractable to adequate trials of,conventional treatment in:,? bronchial asthma,? drug hypersensitivity reactions,? contact dermatitis,? urticarial transfusion reactions,? atopic dermatitis,? serum sickness,? acute noninfectious laryngeal oedema (adrenaline is the drug of first choice),6. ophthalmic diseases,severe acute and chronic allergic and inflammatory processes involving the eye, such,as:,? herpes zoster ophthalmicus,? iritis, iridocyclitis,? chorioretinitis,? diffuse posterior uveitis and choroiditis,? optic neuritis,? sympathetic ophthalmia,? anterior segment inflammation,? allergic conjunctivitis,? allergic corneal marginal ulcers,? keratitis,7. gastrointestinal diseases,to tide the patient over a critical period of the disease in:,? ulcerative colitis (systemic therapy),? regional enteritis (systemic therapy),8. respiratory diseases,? symptomatic sarcoidosis,? loeffler?s syndrome not manageable by other means,? berylliosis,? fulminating or disseminated pulmonary tuberculosis when used concurrently,with appropriate antituberculous chemotherapy,? aspiration pneumonitis,9. haematological disorders,? acquired (autoimmune) haemolytic anaemia,? erythroblastopenia (rbc anaemia),? idiopathic thrombocytopenic purpura in adults (iv only; im administration is,contraindicated),? secondary thrombocytopenia in adults,? congenital (erythroid) hypoplastic anaemia,10. neoplastic diseases,for palliative management of:,? leukaemias and lymphomas in adults,? acute leukaemia in childhood,11. oedematous states,? to induce diuresis or remission of proteinuria in the nephrotic syndrome, without,uraemia, of the idiopathic type or that due to lupus erythematosus,12. miscellaneous,? tuberculous meningitis with subarachnoid block or impending block when used,concurrently with appropriate antituberculous chemotherapy,? trichinosis with neurological or myocardial involvement

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - hydrocortisone sodium phosphate - solution for injection - 100mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - hydrocortisone sodium phosphate - solution for injection - 100mg/1ml

United States - English - NLM (National Library of Medicine)

meda pharmaceuticals inc. - hydrocortisone acetate (unii: 3x7931po74) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone acetate 1500 mg in 15 g - cortifoam® is indicated as adjunctive therapy in the topical treatment of ulcerative proctitis of the distal portion of the rectum in patients who cannot retain hydrocortisone or other corticosteroid enemas. cortifoam® is contraindicated in patients who are hypersensitive to any components of this product. local contraindications to the use of intrarectal steroids include obstruction, abscess, perforation, peritonitis, fresh intestinal anastomoses, extensive fistulas and sinus tracts.